Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Mutations of TGFbeta signaling molecules in human disease.

Harradine KA, Akhurst RJ.

Ann Med. 2006;38(6):403-14. Review. Erratum in: Ann Med. 2007;39(1):79.

PMID:
17008304
2.
3.
4.

Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.

Gomez-Duran A, Carvajal-Gonzalez JM, Mulero-Navarro S, Santiago-Josefat B, Puga A, Fernandez-Salguero PM.

Biochem Pharmacol. 2009 Feb 15;77(4):700-12. doi: 10.1016/j.bcp.2008.08.032. Epub 2008 Sep 5. Review.

PMID:
18812170
5.

Escaping from the TGFbeta anti-proliferative control.

Seoane J.

Carcinogenesis. 2006 Nov;27(11):2148-56. Epub 2006 May 12. Review.

PMID:
16698802
6.

Endofin acts as a Smad anchor for receptor activation in BMP signaling.

Shi W, Chang C, Nie S, Xie S, Wan M, Cao X.

J Cell Sci. 2007 Apr 1;120(Pt 7):1216-24. Epub 2007 Mar 13.

7.

Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.

Sato S, Futakuchi M, Ogawa K, Asamoto M, Nakao K, Asai K, Shirai T.

Cancer Sci. 2008 Feb;99(2):316-23. doi: 10.1111/j.1349-7006.2007.00690.x.

8.

Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.

Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.

Mol Pharmacol. 2007 Jul;72(1):152-61. Epub 2007 Mar 30.

9.
10.

Transforming Growth Factor-beta superfamily: evaluation as breast cancer biomarkers and preventive agents.

Gupta V, Harkin DP, Kawakubo H, Maheswaran S.

Curr Cancer Drug Targets. 2004 Mar;4(2):165-82. Review.

PMID:
15032667
11.

Targeting TGFbeta signaling for cancer therapy.

Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P.

Cancer Biol Ther. 2005 Mar;4(3):261-6. Epub 2005 Mar 28. Review.

PMID:
15846079
12.

Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.

Cocolakis E, Dai M, Drevet L, Ho J, Haines E, Ali S, Lebrun JJ.

J Biol Chem. 2008 Jan 18;283(3):1293-307. Epub 2007 Nov 17.

13.

TGF beta inhibition for cancer therapy.

Saunier EF, Akhurst RJ.

Curr Cancer Drug Targets. 2006 Nov;6(7):565-78. Review.

PMID:
17100564
14.

Regulating the stability of TGFbeta receptors and Smads.

Lönn P, Morén A, Raja E, Dahl M, Moustakas A.

Cell Res. 2009 Jan;19(1):21-35. doi: 10.1038/cr.2008.308. Review.

PMID:
19030025
15.

Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.

Prokova V, Mavridou S, Papakosta P, Petratos K, Kardassis D.

Biochemistry. 2007 Dec 4;46(48):13775-86. Epub 2007 Nov 10.

PMID:
17994767
16.

Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction.

Chen F, Desai TJ, Qian J, Niederreither K, Lü J, Cardoso WV.

Development. 2007 Aug;134(16):2969-79. Epub 2007 Jul 18.

17.

Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions.

Wiater E, Harrison CA, Lewis KA, Gray PC, Vale WW.

J Biol Chem. 2006 Jun 23;281(25):17011-22. Epub 2006 Apr 18.

18.

Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.

Tsuchida K, Nakatani M, Uezumi A, Murakami T, Cui X.

Endocr J. 2008 Mar;55(1):11-21. Epub 2007 Sep 14. Review.

19.

Roles of TGFbeta in metastasis.

Padua D, Massagué J.

Cell Res. 2009 Jan;19(1):89-102. doi: 10.1038/cr.2008.316. Review.

PMID:
19050696
20.

Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6.

Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F, Richter W.

J Cell Physiol. 2007 Jun;211(3):682-91.

PMID:
17238135

Supplemental Content

Support Center